| Literature DB >> 32660122 |
Masayuki Okuda1, Aya Fujiwara2,3, Satoshi Sasaki3.
Abstract
Reduction in the intakes of added and free sugars is a recommendation to lower cardiometabolic risks. Sugars intake is considered lowest in the Asian-Pacific region, particularly Japan. We examined the association between sugars intake and cardiometabolic risks in Japanese adolescents. We included 3242 students (mean age, 13.56 years) living in Shunan City, Japan, between 2006 and 2010. Sugars intake was estimated using the brief-type self-administered diet history questionnaire. Anthropometrics, serum lipids, fasting plasma glucose, and blood pressure were measured. Metabolic syndrome was determined by the combination of overweight and other risks. Intakes of added and free sugars were 7.6-7.9%E and 8.4-8.8%E of the total energy intake (%E), respectively. Categories based on quintiles of added or free sugars intakes were associated with fasting glucose, systolic blood pressure, and the z-score of metabolic syndrome (Ptrend ≤ 0.025). Other than the association between added sugars ≥10%E and high glucose (odds ratio 1.51, 95% confidence interval 1.04-2.19, p = 0.031), non-significantly high intakes of added or free sugars for risks occurred. Association was observed between added or free sugars intake and cardiometabolic biomarkers in Japanese adolescents, and added sugars intake <10%E could prevent glucose intolerance but not metabolic syndrome.Entities:
Keywords: Japanese; added sugars; adolescents; cardiovascular risks; free sugars; metabolic syndrome
Mesh:
Substances:
Year: 2020 PMID: 32660122 PMCID: PMC7400823 DOI: 10.3390/nu12072046
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Subjects’ selection.
Characteristics of the study participants.
| Males, | Females, | |
|---|---|---|
| Age, years | 13.56 ± 0.29 | 13.56 ± 0.29 |
| BMI, kg/m2 | 19.0 ± 2.7 | 19.5 ± 2.7 |
| zBMI | 0.01 ± 1.06 | 0.13 ± 1.07 |
| Total energy, kcal/day | 2414 ± 655 | 2014 ± 538 |
| Carbohydrate, %E | 55.3 ± 6.7 | 53.2 ± 6.4 |
| Added sugars, %E | 7.6 ± 4.0 | 7.9 ± 4.1 |
| Free sugars, %E | 8.4 ± 4.4 | 8.8 ± 4.6 |
| Overweight (IOTF) | 154 (9.3) | 148 (9.4) |
| Overweight (≥1 SD) | 265 (16.0) | 307 (19.4) |
| High LDL (≥120 mg/dL) | 122 (7.4) | 166 (10.5) |
| Low HDL (<40 mg/dL) | 20 (1.2) | 8 (0.5) |
| High TG (≥150 mg/dL) | 34 (2.1) | 27 (1.7) |
| High Glu (≥100 mg/dL) | 106 (6.4) | 47 (3.0) |
| High SBP (≥130 mmHg) | 211 (12.7) | 92 (5.8) |
| High DBP (≥185 mmHg) | 48 (2.9) | 60 (3.8) |
| High BP (high SBP, or high DBP) | 232 (14.0) | 134 (8.5) |
| MS (IOTF) | 14 (0.8) | 6 (0.4) |
| MS (≥1 SD) | 17 (1.0) | 9 (0.6) |
Data are presented as mean ± SD or counts (%). BMI, body mass index; zBMI, z-score of BMI; %E, percentage of total energy intake; IOTF, International Obesity Task Force; SD, standard deviation; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; TG, triglyceride; Glu, fasting glucose, SBP and DBP, systolic and diastolic blood pressure; MS, metabolic syndrome. Metabolic syndrome was determined as overweight (IOTF, or ≥1 SD) plus two or more risks of low HDL, high TG, high fasting glucose, and high BP.
Least square means of risk parameters according to quintile categories of sugars intake.
| Q1 | Q2 | Q3 | Q4 | Q5 |
| |
|---|---|---|---|---|---|---|
|
| 647 | 649 | 650 | 648 | 648 | |
|
| 3.36 ± 0.83 | 5.37 ± 0.49 | 6.99 ± 0.53 | 8.89 ± 0.71 | 14.01 ± 3.87 | |
| zBMI | 0.11 | 0.10 | 0.03 | 0.01 | 0.08 | 0.289 |
| LDL, mg/dL | 88.8 | 90.1 | 89.8 | 89.8 | 90.2 | 0.393 |
| HDL, mg/dL | 67.3 | 67.7 | 68.4 | 67.7 | 67.2 | 0.883 |
| TG, mg/dL | 58.3 | 59.1 | 57.2 | 59.6 | 59.1 | 0.587 |
| Glu, mg/dL | 89.5 | 89.7 | 89.9 | 90.5 | 90.8 |
|
| SBP, mmHg | 112.7 | 114.4 | 114.1 | 114.9 | 115.0 |
|
| DBP, mmHg | 67.8 | 68.2 | 67.8 | 68.3 | 68.5 | 0.152 |
| zMS | −0.06 | 0.00 | −0.04 | 0.04 | 0.06 |
|
|
| 647 | 649 | 649 | 649 | 648 | |
|
| 3.73 ± 0.96 | 5.97 ± 0.56 | 7.78 ± 0.59 | 9.9 ± 0.76 | 15.58 ± 4.28 | |
| zBMI | 0.13 | 0.07 | 0.05 | −0.01 | 0.09 | 0.277 |
| LDL, mg/dL | 89.0 | 88.9 | 90.1 | 90.1 | 90.6 | 0.113 |
| HDL, mg/dL | 67.2 | 68.2 | 68.3 | 67.7 | 67.0 | 0.513 |
| TG, mg/dL | 58.7 | 57.3 | 58.4 | 60.9 | 58.1 | 0.532 |
| Glu, mg/dL | 89.6 | 89.5 | 90.2 | 90.3 | 90.8 |
|
| SBP, mmHg | 113.0 | 114.7 | 114.0 | 114.7 | 114.7 |
|
| DBP, mmHg | 67.7 | 68.6 | 67.9 | 67.8 | 68.6 | 0.404 |
| zMS | −0.05 | −0.01 | −0.02 | 0.02 | 0.05 |
|
Data are presented as mean intake ± standard deviation. %E, percentage of total energy intake; zBMI, z-score of body mass index LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; TG, triglyceride; Glu; fasting glucose; SBP, and DBP, systolic and diastolic blood pressure; zMS, z-score of metabolic syndrome is calculated as the mean of the z-scores of BMI, HDL (inversed), TG, Glu, SBP, and DBP. Least square means were adjusted for age, gender, sleeping duration, number of siblings, single parent, physical activity, total energy, fat, and total dietary fiber. Parameters other than zBMI were additionally adjusted for zBMI. P indicates the tests of simple linear trends of the risk levels among the ranked categories of sugars intake.
Odds ratios of high sugars intake for overweight, high LDL, TG, Glu, SBP, DBP or BP, low HDL, and MS.
| Added Sugars Intake | Free Sugars Intake | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Low (ref.) | High | OR | (95% CI) |
| Low (ref.) | High | OR | (95% CI) |
| |
|
| 822 | 2420 | 632 | 2610 | ||||||
| Overweight (IOTF) | 86 (10.5) | 216 (8.9) | 0.95 | (0.72, 1.26) | 0.744 | 67 (10.6) | 235 (9.0) | 0.97 | (0.71, 1.31) | 0.819 |
| Overweight (≥1 SD) | 154 (18.7) | 418 (17.3) | 0.98 | (0.79, 1.21) | 0.841 | 119 (18.8) | 453 (17.4) | 0.98 | (0.78, 1.24) | 0.874 |
| High LDL | 59 (7.2) | 229 (9.5) | 1.29 | (0.94, 1.76) | 0.112 | 44 (7.0) | 244 (9.3) | 1.32 | (0.94, 1.87) | 0.113 |
| Low HDL | 6 (0.7) | 22 (0.9) | 1.38 | (0.53, 3.58) | 0.511 | 5 (0.8) | 23 (0.9) | 1.26 | (0.46, 3.5) | 0.653 |
| High TG | 21 (2.6) | 40 (1.7) | 0.79 | (0.45, 1.41) | 0.429 | 17 (2.7) | 44 (1.7) | 0.78 | (0.43, 1.43) | 0.419 |
| High Glu | 32 (3.9) | 121 (5.0) | 1.25 | (0.83, 1.90) | 0.291 | 27 (4.3) | 126 (4.8) | 1.11 | (0.71, 1.73) | 0.641 |
| High SBP | 77 (9.4) | 226 (9.3) | 1.20 | (0.89, 1.60) | 0.233 | 60 (9.5) | 243 (9.3) | 1.20 | (0.87, 1.65) | 0.262 |
| High DBP | 26 (3.2) | 82 (3.4) | 1.10 | (0.69, 1.75) | 0.704 | 17 (2.7) | 91 (3.5) | 1.36 | (0.79, 2.34) | 0.273 |
| High BP | 92 (11.2) | 274 (11.3) | 1.15 | (0.88, 1.51) | 0.300 | 71 (11.2) | 295 (11.3) | 1.16 | (0.87, 1.56) | 0.309 |
| MS (IOTF) | 6 (0.7) | 14 (0.6) | 1.24 | (0.36, 4.28) | 0.738 | 5 (0.8) | 15 (0.6) | 1.22 | (0.34, 4.41) | 0.765 |
| MS (≥1 SD) | 6 (0.7) | 20 (0.8) | 1.53 | (0.51, 4.60) | 0.452 | 5 (0.8) | 21 (0.8) | 1.53 | (0.47, 4.94) | 0.481 |
|
| 2551 | 691 | 2319 | 923 | ||||||
| Overweight (IOTF) | 237 (9.3) | 65 (9.4) | 1.05 | (0.78, 1.41) | 0.763 | 216 (9.3) | 86 (9.3) | 1.03 | (0.79, 1.35) | 0.830 |
| Overweight (≥1 SD) | 452 (17.7) | 120 (17.4) | 0.99 | (0.79, 1.24) | 0.918 | 417 (18) | 155 (16.8) | 0.93 | (0.75, 1.14) | 0.460 |
| High LDL | 213 (8.3) | 75 (10.9) | 1.26 | (0.95, 1.68) | 0.113 | 195 (8.4) | 93 (10.1) | 1.17 | (0.89, 1.52) | 0.263 |
| Low HDL | 22 (0.9) | 6 (0.9) | 1.04 | (0.41, 2.63) | 0.942 | 21 (0.9) | 7 (0.8) | 0.86 | (0.36, 2.08) | 0.744 |
| High TG | 54 (2.1) | 7 (1.0) | 0.50 | (0.22, 1.12) | 0.093 | 51 (2.2) | 10 (1.1) | 0.53 | (0.26, 1.06) | 0.071 |
| High Glu | 109 (4.3) | 44 (6.4) | 1.51 | (1.04, 2.19) |
| 102 (4.4) | 51 (5.5) | 1.28 | (0.90, 1.82) | 0.171 |
| High SBP | 243 (9.5) | 60 (8.7) | 0.94 | (0.69, 1.28) | 0.683 | 222 (9.6) | 81 (8.8) | 0.97 | (0.73, 1.28) | 0.826 |
| High DBP | 88 (3.4) | 20 (2.9) | 0.85 | (0.51, 1.41) | 0.529 | 77 (3.3) | 31 (3.4) | 1.03 | (0.67, 1.59) | 0.891 |
| High BP | 293 (11.5) | 73 (10.6) | 0.94 | (0.70, 1.24) | 0.642 | 265 (11.4) | 101 (10.9) | 1.00 | (0.78, 1.29) | 0.999 |
| MS (IOTF) | 18 (0.7) | 2 (0.3) | 0.61 | (0.12, 3.12) | 0.551 | 17 (0.7) | 3 (0.3) | 0.63 | (0.15, 2.63) | 0.528 |
| MS (≥1 SD) | 22 (0.9) | 4 (0.6) | 0.95 | (0.29, 3.07) | 0.930 | 20 (0.9) | 6 (0.7) | 1.04 | (0.37, 2.93) | 0.939 |
Data are presented as n (%). %E, percentage of total energy intake; IOTF, International Obesity Task Force; SD, standard deviation; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; TG, triglyceride; Glu, fasting glucose; BP, blood pressure; MS, metabolic syndrome. MS was determined as overweight (IOTF or ≥1 SD) plus two or more risks of low HDL, high TG, high Glu, and high BP; OR, odds ratio; CI, confidence interval. ORs were adjusted for age, gender, sleeping duration, number of siblings, single parent, physical activity, total energy, fat, and total dietary fiber. ORs, for cardiometabolic risks other than overweight, were additionally adjusted for a z-score of BMI.